A new market study, titled “Small Molecule Drug Discovery – Global Market Outlook (2017-2026)” has been featured on WiseGuyReports.
According to research study, the Global Small Molecule Drug Discovery Market is expected to grow at a CAGR of 8.5% during the forecast period. Some of the factors such as rise in drug discovery and development and rising usage of these drugs in the treatment of chronic diseases are driving the market growth. However, high costs of drugs are hindering the market growth.
Small molecule drug is a substance that can quickly enter the cells due to its low molecular weight. After entering the cells, it may affect the other molecules like proteins and may cause the cancer cells to die. There are two phases of developing new small molecule drugs. One is Drug discovery, and the other one is Drug development. Small molecule drugs are different from other drugs which have a large molecular weight. So, these targeted therapies are small-molecule drugs or small molecule inhibitors.
By Process Phase, lead optimization segment held significant growth during the forecast period due to increasing strength, selectivity, or pharmacokinetic parameters, rising in cancer and other diseases encouraging investments in lead optimization. Based on geography, North America is anticipated to be one of the leading regions contributing to the global market during the forecast period. There is an increasing number of contract organizations for research and development. This shows that the United States is focusing on R&D activities to meet the rising demands of its people, finally leading the market of North America.
Some of the key players profiled in the Small Molecule Drug Discovery Market include Astrazeneca, Boehringer Ingelheim Gmbh, Bristol- Myers Squibb, Gilead Sciences, Inc., Glaxosmithkline, Johnson & Johnson, Merck & Co., Pfizer Inc and Teva Pharmaceuticals.
Process Phases Covered:
- Hit Generation and Selection
- Lead Identification
- Lead Optimization
- Target Id/Validation
Request Sample Report at https://www.wiseguyreports.com/sample-request/3679686-small-molecule-drug-discovery-global-market-outlook-2017-2026
Therapeutic Areas Covered:
- Anti-Infective
- Cardiovascular
- Central Nervous System
- Dermatology
- Gastrointestinal
- Immunological
- Metabolic
- Oncology
- Orthopedics
- Respiratory
- Other Therapeutic Areas
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
- South America
o Argentina
o Brazil
o Chile
o Rest of South America
- Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
Table of Content
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Small Molecule Drug Discovery Market, By Process Phase
6 Global Small Molecule Drug Discovery Market, By Therapeutic Area
7 Global Small Molecule Drug Discovery Market, By Geography
8 Key Developments
9 Company Profiling
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.